ES2105984B1 - RECOMBINANT ADENOVIRUSES THAT EXPRESS TRANSMISSIBLE SWINE GASTROENTERITIS VIRUS ANTIGENS (VGPT) AND THEIR USE IN THE FORMATION OF VACCINES. - Google Patents

RECOMBINANT ADENOVIRUSES THAT EXPRESS TRANSMISSIBLE SWINE GASTROENTERITIS VIRUS ANTIGENS (VGPT) AND THEIR USE IN THE FORMATION OF VACCINES.

Info

Publication number
ES2105984B1
ES2105984B1 ES09502370A ES9502370A ES2105984B1 ES 2105984 B1 ES2105984 B1 ES 2105984B1 ES 09502370 A ES09502370 A ES 09502370A ES 9502370 A ES9502370 A ES 9502370A ES 2105984 B1 ES2105984 B1 ES 2105984B1
Authority
ES
Spain
Prior art keywords
vgpt
vaccines
recombinant adenoviruses
gastroenteritis virus
express
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09502370A
Other languages
Spanish (es)
Other versions
ES2105984A1 (en
Inventor
Duran Juan Plana
Luis Enjuanes
Juan Maria Torres
Carlos Miguel Sanchez
Cristian Smerdou
Carles Sune
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Farma SA
Original Assignee
Cyanamid Iberica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyanamid Iberica SA filed Critical Cyanamid Iberica SA
Priority to ES09502370A priority Critical patent/ES2105984B1/en
Priority to AU71325/96A priority patent/AU7132596A/en
Priority to PCT/ES1996/000185 priority patent/WO1997020036A1/en
Publication of ES2105984A1 publication Critical patent/ES2105984A1/en
Application granted granted Critical
Publication of ES2105984B1 publication Critical patent/ES2105984B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

ADENOVIRUS RECOMBINANTES QUE EXPRESAN ANTIGENOS DEL VIRUS DE LA GASTROENTERITIS PORCIONA TRANSMISIBLE (VGPT) Y SU EMPLEO EN LA FORMULACION DE VACUNAS. LOS ADENOVIRUS RECOMBINANTES CONTIENEN EN SU GENOMA LA SECUENCIA DEL GEN S DEL VIRUS DE LA GASTROENTERITIS PORCINA TRANSMISIBLE (VGPT) O; UNA SECUENCIA DERIVADA DE DICHO GEN QUE CONTIENE, AL MENOS, UNO DE LOS SITIOS ANTIGENICOS DE LA PROTEINA S DEL VGPT. ESTOS ADENOVIRUS RECOMBINANTES PUEDEN UTILIZARSE EN LA FORMULACION DE VACUNAS PARA PROTEGER AL GANADO PORCINO DE LA INFECCION POR VGPT Y CONTRA LA ENFERMEDAD CAUSADA POR DICHO VIRUS. ESTA INVENCION TIENE INTERES EN VETERINARIA.RECOMBINANT ADENOVIRUSES THAT EXPRESS ANTIGENS OF THE TRANSMISSIBLE PORTIONAL GASTROENTERITIS VIRUS (VGPT) AND ITS USE IN THE FORMULATION OF VACCINES. RECOMBINANT ADENOVIRUSES CONTAIN IN THEIR GENOME THE SEQUENCE OF THE S GENE OF THE TRANSMISSIBLE SWINE GASTROENTERITIS VIRUS (VGPT) OR; A SEQUENCE DERIVED FROM SUCH A GENE CONTAINING AT LEAST ONE OF THE ANTIGENIC SITES OF THE VGPT PROTEIN S. THESE RECOMBINANT ADENOVIRUSES MAY BE USED IN THE FORMULATION OF VACCINES TO PROTECT THE SWINE CATTLE FROM VGPT INFECTION AND AGAINST THE DISEASE CAUSED BY SUCH VIRUSES. THIS INVENTION HAS INTEREST IN VETERINARY.

ES09502370A 1995-11-30 1995-11-30 RECOMBINANT ADENOVIRUSES THAT EXPRESS TRANSMISSIBLE SWINE GASTROENTERITIS VIRUS ANTIGENS (VGPT) AND THEIR USE IN THE FORMATION OF VACCINES. Expired - Fee Related ES2105984B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES09502370A ES2105984B1 (en) 1995-11-30 1995-11-30 RECOMBINANT ADENOVIRUSES THAT EXPRESS TRANSMISSIBLE SWINE GASTROENTERITIS VIRUS ANTIGENS (VGPT) AND THEIR USE IN THE FORMATION OF VACCINES.
AU71325/96A AU7132596A (en) 1995-11-30 1996-10-01 Recombinant adenoviruses which express antigens of the transmissible porcine gastroenteritis virus and use thereof in the formulation of vaccines
PCT/ES1996/000185 WO1997020036A1 (en) 1995-11-30 1996-10-01 Recombinant adenoviruses which express antigens of the transmissible porcine gastroenteritis virus and use thereof in the formulation of vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09502370A ES2105984B1 (en) 1995-11-30 1995-11-30 RECOMBINANT ADENOVIRUSES THAT EXPRESS TRANSMISSIBLE SWINE GASTROENTERITIS VIRUS ANTIGENS (VGPT) AND THEIR USE IN THE FORMATION OF VACCINES.

Publications (2)

Publication Number Publication Date
ES2105984A1 ES2105984A1 (en) 1997-10-16
ES2105984B1 true ES2105984B1 (en) 1998-04-16

Family

ID=8292359

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09502370A Expired - Fee Related ES2105984B1 (en) 1995-11-30 1995-11-30 RECOMBINANT ADENOVIRUSES THAT EXPRESS TRANSMISSIBLE SWINE GASTROENTERITIS VIRUS ANTIGENS (VGPT) AND THEIR USE IN THE FORMATION OF VACCINES.

Country Status (3)

Country Link
AU (1) AU7132596A (en)
ES (1) ES2105984B1 (en)
WO (1) WO1997020036A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO856097A0 (en) 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
FR2789695B1 (en) * 1999-02-11 2003-03-07 Merial Sas VIRAL VACCINES AND VACCINES BASED ON RECOMBINANT AND REPLICATIVE SWINE ADENOVIRUSES
US7569217B2 (en) 2001-09-24 2009-08-04 University Of Saskatchewan Porcine adenovirus E1 and E4 regions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU657907B2 (en) * 1990-05-29 1995-03-30 Wyeth Holdings Corporation Mycoplasma hyopneumoniae vaccine

Also Published As

Publication number Publication date
WO1997020036A1 (en) 1997-06-05
AU7132596A (en) 1997-06-19
ES2105984A1 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
EA202192570A1 (en) IMMUNOGENIC COMPOSITIONS AND VACCINES CONTAINING AFRICAN SWINE FEVER VIRUS PEPTIDES AND PROTEINS AND THEIR APPLICATION
DE69632235D1 (en) Newcastle disease viral vaccines combined
CY1110359T1 (en) CIRCULAR SWINE-based vaccine
AR042378A2 (en) MAPACHE RECOMBINANT POXVIRUS, VACCINE FOR USE IN CATS AND USE OF SUCH POXVIRUS TO PREPARE AN EFFECTIVE VACCINE AGAINST INFECTION OF THE FELINE IMMUNODEFICIENCY VIRUS
BRPI0510928A (en) identification of virally infected and vaccinated organisms
ES2143507T3 (en) VACCINES AGAINST AUJESZKY DISEASE AND OTHER ANIMAL DISEASES CONTAINING MUTANTS OF PSEUDORRABIA VIRUSES.
ATE233101T1 (en) POLYNUCLEOTIDE VACCINE AGAINST PAPILLOMA VIRUS
AR014182A1 (en) COMPOSITIONS OF USEFUL VACCINES FOR THE TREATMENT OR PROFILAXIS OF TUMORS OR INJURIES DUE TO HPV; PROCEDURE TO PREVENT OR TREAT TUMORS INDUCED BY HPV AND PROCEDURE TO PREPARE SUCH COMPOSITIONS
ES2070997T3 (en) RECOMBINANT HERPES VIRUSES OF TURKEYS AND LIVING VECTOR VACCINES DERIVED FROM THEM.
ES2165405T3 (en) EUROPEAN VACCINE BREEDS OF THE SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV).
ES2140418T3 (en) CHEMICAL FLAVIVIRUS AND / OR RESTRICTED GROWTH FLAVIVIRUS.
HUP9802819A2 (en) Heat shock protein-based vaccines and immunotherapies
BR0111366A (en) Recombinant Porcine Respiratory and Respiratory Syndrome Virus (prrsv) Vaccine
BR9807873A (en) Chimeric flavivir vaccines
ES2061996T3 (en) NON-ESSENTIAL REGIONS OF AVIPOXVIRUSES.
PE20030285A1 (en) SINGLE DOSE VACCINATION WITH MYCOPLASMA HYOPNEUMONIAE
BR9814606A (en) Vaccine formulation and methods of treating an individual infected with an hpv virus and preventing papillomavirus infection
DE60110822D1 (en) PREPARING FOR IMMUNIZING AGAINST THE AIDS VIRUS
ATE420190T1 (en) RECOMBINANT LIVE VACCINE CONTAINING FELINE HERPES VIRUS TYPE I, ESPECIALLY FOR THE TREATMENT OF INFECTIOUS PERIMONITIS IN CATS
BR9814204A (en) "obtaining vaccines designed to prevent the pathogenic effects associated with a retroviral infection"
ES2145000T3 (en) RECOMBINANT VIRUSES OF THE AVIPOX.
ES2196032T3 (en) MUTANTS AND VACCINES OF THE VIRUSES OF THE INFECTIOUS ANEMIA OF THE CHICKENS AND USES BASED ON THE VIRAL PROTEINS VP1, VP2 AND VP3 OR SEQUENCES OF SUCH VIRUS CODING THEM.
ES2105984B1 (en) RECOMBINANT ADENOVIRUSES THAT EXPRESS TRANSMISSIBLE SWINE GASTROENTERITIS VIRUS ANTIGENS (VGPT) AND THEIR USE IN THE FORMATION OF VACCINES.
CO5280138A1 (en) DAMAGED AND INNOCUTIVE VIRUSES OF THE VIRICA BOVINA DIARREA FOR IN MANAGING COWS
CY1109023T1 (en) GM-NEGATIVE EHV MUTUALS

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19971016

Kind code of ref document: A1

Effective date: 19971016

FD1A Patent lapsed

Effective date: 20100803